Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Tissue Cell ; 88: 102402, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38759523

ABSTRACT

GATA3 plays critical roles in the development and function of various tissues and organs throughout the body. Likewise, TGF-ß signaling is critical for placental development and can interact with GATA3. We aimed to investigate the involvement of the multifunctional cytokine and transcription factor in trophoblast development. By using immunohistochemistry, we evaluated the localization and expression level of GATA3 and TGF-ß in placentas at term of normal pregnancy and with pre-eclampsia. Up-regulation of both GATA3 and TGF-ß was observed in pathological placentas, with localization in the villus epithelium (syncytiotrophoblast) stroma and decidua. Our data show altered expression of TGF-ß and GATA3, which downstream could lead to a cascade of events that negatively influence trophoblast development and contribute to the pathogenesis of pre-eclampsia.


Subject(s)
GATA3 Transcription Factor , Placenta , Pre-Eclampsia , Transforming Growth Factor beta , Pre-Eclampsia/metabolism , Pre-Eclampsia/pathology , Humans , Pregnancy , Female , GATA3 Transcription Factor/metabolism , Placenta/metabolism , Placenta/pathology , Transforming Growth Factor beta/metabolism , Adult , Trophoblasts/metabolism , Trophoblasts/pathology
2.
J Diet Suppl ; 20(2): 372-389, 2023.
Article in English | MEDLINE | ID: mdl-36729019

ABSTRACT

Nutraceuticals have for several years aroused the interest of researchers for their countless properties, including the management of viral infections. In the context of the COVID-19 pandemic, studies and research on the antiviral properties of nutraceuticals have greatly increased. More specifically, over the past two years, researchers have focused on analyzing the possible role of nutraceuticals in reducing the risk of SARS-CoV-2 infection or mitigating the symptoms of COVID-19. Among nutraceuticals, turmeric, extracted from the rhizome of the Curcuma Longa plant, and spirulina, commercial name of the cyanobacterium Arthrospira platensis, have assumed considerable importance in recent years. The purpose of this review is to collect, through a search of the most recent articles on Pubmed, the scientific evidence on the role of these two compounds in the fight against COVID-19. In the last two years many hypotheses, some confirmed by clinical and experimental studies, have been made on the possible use of turmeric against COVID-19, while on spirulina and its possible role against SARS-CoV-2 infection information is much less. The demonstrated antiviral properties of spirulina and the fact that these cyanobacteria may modulate or modify some mechanisms also involved in the onset of COVID-19, lead us to think that it may have the same importance as curcumin in fighting this disease and to speculate on the possible combined use of these two substances to obtain a synergistic effect.


Subject(s)
COVID-19 , Curcumin , Spirulina , Humans , Curcumin/pharmacology , Curcumin/therapeutic use , SARS-CoV-2 , Pandemics , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use
3.
Biology (Basel) ; 12(2)2023 Jan 21.
Article in English | MEDLINE | ID: mdl-36829453

ABSTRACT

During pregnancy, SARS-CoV-2 infection is associated with several adverse outcomes, including an increased risk of pre-eclampsia, preterm delivery, hypertensive disorders, gestational diabetes, and fetal growth restriction related to the development of placenta vascular abnormalities. We analyzed human placenta from full-term, uncomplicated pregnancies with SARS-CoV-2 infection during the first, second, or third trimesters of gestation. We studied, by the immunohistochemistry technique, the expression of CD34 and podoplanin (PDPN) as markers of vasculogenesis to find any differences. As secondary outcomes, we correlated maternal symptoms with placental histological alterations, including fibrin deposits, lymphocyte infiltration in the villi, edema, and thrombi. Our results showed a PDPN expression around the villous stroma as a plexiform network around the villous nucleus of fetal vessels; significant down-regulation was observed in the villous stroma of women infected during the third trimester. CD34 showed no changes in expression levels. During SARS-CoV-2 infection, the most common maternal symptoms were fever, anosmia, ageusia and asthenia, and the majority were treated with paracetamol, corticosteroids and azithromycin. Patients that required multiple symptomatic treatments evidenced a large amount of fibrin deposition in the villi. Certainly, PDPN plays a key role in healthy placental vasculogenesis and thus in its proper physiology, and SARS-CoV-2 surely alters its normal expression. Further studies are necessary to understand what mechanisms are being altered to try to avoid possible complications for both the mother and fetus in terms of the contagions that will still occur.

4.
AIDS ; 37(4): 561-570, 2023 03 15.
Article in English | MEDLINE | ID: mdl-36504092

ABSTRACT

OBJECTIVE: Integrase strand transfer inhibitors (INSTIs) are a class of antiretroviral therapy (ART) medications with a good tolerability profile and a high genetic barrier to HIV drug resistance. However, several studies report significant weight gain among persons receiving INSTI-based ART regimens compared with other regimens. DESIGN: In-vitro model of adipogenesis. METHODS: We used 3T3-L1 cells to investigate the effects of the nucleoside reverse transcriptase inhibitors (NRTIs) tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF), alone or in combination with INSTIs: raltegravir (RAL), elvitegravir (ELV), dolutegravir (DTG), and bictegravir (BIC) on adipose differentiation. To monitor adipocyte differentiation, expression levels of PPARÉ£ and C/EBPα and the intracellular lipid accumulation by Red Oil staining were used. Furthermore, we evaluated the immunohistochemical expression of ER-TR7, a fibroblastic marker, after INSTIs treatment. RESULTS: Compared with control, INSTIs were able to increase adipogenesis, especially RAL and ELV. TAF and TDF inhibited adipogenesis alone and in combination with INSTIs. This ability was more evident when TAF was used in combination with DTG and BIC. Finally, INSTIs increased the expression of ER-TR7 compared with control and cells treated with TAF or TDF. CONCLUSION: Our data support the evidence that in-vitro challenge of 3T3-L1 cells with INSTIs is able to increase adipocytic differentiation and to drive a number of these cells toward the expression of fibroblastic features, with a different degree according to the various drugs used whereas TAF and TDF have an antagonistic role on this phenomenon.


Subject(s)
Anti-HIV Agents , HIV Infections , Humans , Mice , Animals , Tenofovir/therapeutic use , HIV Infections/drug therapy , Anti-HIV Agents/therapeutic use , 3T3-L1 Cells , Adenine/therapeutic use , Raltegravir Potassium/therapeutic use , Cell Differentiation , Adipocytes , Integrases/therapeutic use
5.
Int J Mol Sci ; 23(22)2022 Nov 17.
Article in English | MEDLINE | ID: mdl-36430727

ABSTRACT

Tumor diseases are unfortunately quick spreading, even though numerous studies are under way to improve early diagnosis and targeted treatments that take into account both the different characteristics associated with the various tumor types and the conditions of individual patients. In recent years, studies have focused on the role of ion channels in tumor development, as these proteins are involved in several cellular processes relevant to neoplastic transformation. Among all ion channels, many studies have focused on the superfamily of Transient Receptor Potential (TRP) channels, which are non-selective cation channels mediating extracellular Ca2+ influx. In this review, we examined the role of different endothelial TRP channel isoforms in tumor vessel formation, a process that is essential in tumor growth and metastasis.


Subject(s)
Neoplasms , Transient Receptor Potential Channels , Humans , Transient Receptor Potential Channels/genetics , Transient Receptor Potential Channels/metabolism , Protein Isoforms/metabolism
6.
J Cell Mol Med ; 26(12): 3513-3526, 2022 06.
Article in English | MEDLINE | ID: mdl-35593050

ABSTRACT

Increasing the information depth of single kidney biopsies can improve diagnostic precision, personalized medicine and accelerate basic kidney research. Until now, information on mRNA abundance and morphologic analysis has been obtained from different samples, missing out on the spatial context and single-cell correlation of findings. Herein, we present scoMorphoFISH, a modular toolbox to obtain spatial single-cell single-mRNA expression data from routinely generated kidney biopsies. Deep learning was used to virtually dissect tissue sections in tissue compartments and cell types to which single-cell expression data were assigned. Furthermore, we show correlative and spatial single-cell expression quantification with super-resolved podocyte foot process morphometry. In contrast to bulk analysis methods, this approach will help to identify local transcription changes even in less frequent kidney cell types on a spatial single-cell level with single-mRNA resolution. Using this method, we demonstrate that ACE2 can be locally upregulated in podocytes upon injury. In a patient suffering from COVID-19-associated collapsing FSGS, ACE2 expression levels were correlated with intracellular SARS-CoV-2 abundance. As this method performs well with standard formalin-fixed paraffin-embedded samples and we provide pretrained deep learning networks embedded in a comprehensive image analysis workflow, this method can be applied immediately in a variety of settings.


Subject(s)
COVID-19 , Deep Learning , Angiotensin-Converting Enzyme 2 , COVID-19/genetics , Humans , RNA, Messenger/genetics , RNA, Messenger/metabolism , SARS-CoV-2
7.
J Cell Mol Med ; 25(16): 7631-7641, 2021 08.
Article in English | MEDLINE | ID: mdl-34156149

ABSTRACT

Under healthy conditions, foot processes of neighbouring podocytes are interdigitating and connected by an electron-dense slit diaphragm. Besides slit diaphragm proteins, typical adherens junction proteins are also found to be expressed at this cell-cell junction. It is therefore considered as a highly specialized type of adherens junction. During podocyte injury, podocyte foot processes lose their characteristic 3D structure and the filtration slits typical meandering structure gets linearized. It is still under debate how this change of structure leads to the phenomenon of proteinuria. Using super-resolution 3D-structured illumination microscopy, we observed a spatially restricted up-regulation of the tight junction protein claudin-5 (CLDN5) in areas where podocyte processes of patients suffering from minimal change disease (MCD), focal and segmental glomerulosclerosis (FSGS) as well as in murine nephrotoxic serum (NTS) nephritis and uninephrectomy DOCA-salt hypertension models, were locally injured. CLDN5/nephrin ratios in human glomerulopathies and NTS-treated mice were significantly higher compared to controls. In patients, the CLDN5/nephrin ratio is significantly correlated with the filtration slit density as a foot process effacement marker, confirming a direct association of local CLDN5 up-regulation in injured foot processes. Moreover, CLDN5 up-regulation was observed in some areas of high filtration slit density, suggesting that CLND5 up-regulation preceded the changes of foot processes. Therefore, CLDN5 could serve as a biomarker predicting early foot process effacement.


Subject(s)
Claudin-5/metabolism , Glomerulosclerosis, Focal Segmental/pathology , Kidney Diseases/pathology , Kidney Glomerulus/metabolism , Membrane Proteins/metabolism , Podocytes/pathology , Adult , Aged , Aged, 80 and over , Animals , Disease Models, Animal , Female , Glomerulosclerosis, Focal Segmental/metabolism , Humans , Kidney Diseases/metabolism , Kidney Glomerulus/pathology , Male , Mice , Mice, Inbred C57BL , Middle Aged , Podocytes/metabolism
8.
Ear Nose Throat J ; 100(5_suppl): 597S-605S, 2021 Sep.
Article in English | MEDLINE | ID: mdl-31893934

ABSTRACT

Chronic rhinosinusitis with nasal polyps is a multifactorial disease of the nasal and paranasal sinus mucosa and it includes, as comorbidities, anatomic and morphologic alterations, allergic rhinitis, and immunologic diseases. We investigated matrix metalloproteinases (MMP-2, MMP-7, and MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) concentration in different etiopathogenetical groups of patients with nasal polyposis (NP) in relation to recurrence after sinonasal surgery. The study group consisted of 45 patients with NP (those with allergic rhinitis, nonallergic rhinitis and asthma or nonallergic rhinitis, and obstruction of osteomeatal complex [OMC]) who underwent endonasal sinus surgery. We also collected 10 patients who underwent septoplasty as control. Immunohistochemistry of nasal mucosa fragments, Western blotting, and polymerase chain reaction analysis showed increased MMPs levels (MMP-9 more than MMP-2 and MMP-7) and decreased tissue inhibitors of MMPs levels (TIMP-1 less than TIMP-2), in patients with chronic rhinosinusitis with nasal polyps compared with control group, in particular in patients with nonallergic rhinitis and asthma compared to those with allergic rhinitis and nonallergic rhinitis and obstruction of OMC. We observed a higher risk of recurrence in patients with nonallergic rhinitis and asthma than in those with allergic rhinitis and nonallergic rhinitis and obstruction of OMC after 36 months from surgery. In this research, we evaluated pathogenesis of NP related to MMPs and their inhibitors concentrations in polypoid tissue.


Subject(s)
Matrix Metalloproteinases/metabolism , Nasal Polyps/metabolism , Rhinitis/metabolism , Sinusitis/metabolism , Tissue Inhibitor of Metalloproteinases/metabolism , Adult , Aged , Blotting, Western , Chronic Disease , Extracellular Matrix , Female , Humans , Male , Matrix Metalloproteinases/genetics , Middle Aged , Nasal Polyps/complications , Nasal Polyps/surgery , Nasal Septum/surgery , RNA/analysis , Recurrence , Reverse Transcriptase Polymerase Chain Reaction , Rhinitis/complications , Rhinoplasty , Sinusitis/complications , Tissue Inhibitor of Metalloproteinases/genetics
9.
Placenta ; 95: 1-8, 2020 06.
Article in English | MEDLINE | ID: mdl-32339142

ABSTRACT

The placenta, a temporary organ that forms during pregnancy, is the largest fetal organ and the first to develop. It is recognized as an organ that plays a vital role as a metabolic and physical barrier in the fetoplacental unit; throughout fetal development it acts as the lungs, gut, kidneys, and liver of the fetus. When its two components, the fetal and the maternal one, successfully interact, pregnancy proceeds healthily. However, in some cases there may be pregnancy disorders, such as preeclampsia (PE) and gestational diabetes mellitus (GDM), which can lead to a different outcome for the mother and the newborn. In recent years, several studies have been conducted to try to understand how the expression of factors involved in the development of the placenta varies under pathological conditions compared with normal conditions. The purpose of this review is to summarize recent discoveries in this field.


Subject(s)
Nerve Growth Factors/metabolism , Placenta Diseases/metabolism , Placenta/metabolism , Placentation/physiology , Pregnancy Complications/metabolism , Vascular Endothelial Growth Factor A/metabolism , Animals , Female , Humans , Nerve Growth Factors/genetics , Placenta Diseases/genetics , Pregnancy , Pregnancy Complications/genetics , Vascular Endothelial Growth Factor A/genetics
10.
J Cell Physiol ; 235(6): 5041-5049, 2020 06.
Article in English | MEDLINE | ID: mdl-31898324

ABSTRACT

There are many factors contributing to the development of gastrointestinal diseases, grouped into genetic, environmental, and lifestyle factors. In recent years attention has fallen on pathogens; in particular, Bacteroides fragilis, Fusobacterium nucleatum, Escherichia coli (E. coli) and Helicobacter pylori have been studied. Several points remain to be clarified, and above all, as regards the adherent-invasive E. coli strains of E. coli, one wonders if they are a cause or a consequence of the disease. In this review, we have tried to clarify some points by examining a series of recent publications regarding the involvement of the bacterium in the pathology, even if other studies are necessary.


Subject(s)
Crohn Disease/pathology , Dysbiosis/pathology , Inflammatory Bowel Diseases/pathology , Bacteroides fragilis/genetics , Bacteroides fragilis/pathogenicity , Cell Adhesion/genetics , Crohn Disease/genetics , Crohn Disease/microbiology , Dysbiosis/genetics , Dysbiosis/microbiology , Escherichia coli/genetics , Escherichia coli/pathogenicity , Fusobacterium nucleatum/genetics , Fusobacterium nucleatum/pathogenicity , Helicobacter pylori/genetics , Helicobacter pylori/pathogenicity , Humans , Inflammatory Bowel Diseases/genetics , Inflammatory Bowel Diseases/microbiology , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology
11.
Chem Biol Interact ; 310: 108729, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31255636

ABSTRACT

A nutraceutical product can be defined as a substance that has a physiological benefit or provides protection against chronic diseases. The term nutraceutical is a hybrid term derived from the union of "nutrition" and "pharmaceutical". The list of studied nutraceuticals is constantly changing and reflects ongoing market developments, research and consumer interest. Spices, in addition to giving color and taste to foods, are also important nutraceutical. Spices have been an integral part of human diets and commerce for millennia but recently, the recognition of the link between health and nutrition has strengthened their importance in the food sector and sparked the interest of researchers who increasingly engage in trying to determine the mechanisms of action of spices and the countless beneficial properties attributed to them. Among the many existing spices, turmeric is one of the most studied for its antioxidant, anti-inflammatory, antibacterial and anticancer properties. The purpose of this review is to briefly summarize the fundamental characteristics of turmeric and give an overview of the use of this spice in several diseases.


Subject(s)
Curcuma/physiology , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Antioxidants/therapeutic use , Dietary Supplements , Spices
12.
Chem Biol Interact ; 305: 112-118, 2019 May 25.
Article in English | MEDLINE | ID: mdl-30935902

ABSTRACT

Previous studies have demonstrated that different curcumin extracts are able to influence cell metabolic activity vitality in human papillary thyroid carcinoma TPC-1 cells. We continued the study using the most effective extract and adding other nutraceuticals such as piperine and vitamin E, in order to define the possible role of these in modulating the genetic expression of cell markers and to understand the effectiveness in modulating the regression of cancer phenotype. Cells were treated with one extract of curcumin (Naturex® Ultimate Botanical Benefits), with Piperine (Piper Longum, A.C.E.F.) and Vitamin E (Dry Vitamin E-Acetate 50% DC, BASF) alone and in combination, dissolved in the culture medium, for 48 h. Treatment with the different nutraceuticals is able to influence cell cycle regulators (cyclin D1, ß-catenin, p21, p53) and activators or inhibitors of apoptosis (BAX, pro-caspase3, Bcl-2). They are able to influence cell cycle distribution and metabolic activity vitality. The inhibitory effect of curcumin, piperine and vitamin E on cell proliferation involves different markers, and in particular inhibits ß-catenin, cyclinD1 and p53, making them candidates for a possible use in alternative therapies although further studies are needed.


Subject(s)
Cell Proliferation/drug effects , Curcumin/pharmacology , Alkaloids/pharmacology , Apoptosis Regulatory Proteins/metabolism , Benzodioxoles/pharmacology , Cell Cycle Checkpoints/drug effects , Cell Cycle Proteins/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Drug Synergism , Humans , Piperidines/pharmacology , Polyunsaturated Alkamides/pharmacology , Thyroid Cancer, Papillary/metabolism , Thyroid Cancer, Papillary/pathology , Vitamin E/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...